Tatva Chintan Pharma Chem, a specialty chemical manufacturing firm, has filed preliminary papers with the market regulator Sebi for an preliminary public providing (IPO). The IPO will comprise a recent subject of shares price Rs 225 crore and a proposal of sale amounting to Rs 225 crore by current promoters and shareholders, based on the corporate’s draft pink herring prospectus.
Tatva Chintan Pharma Chem will use the IPO proceeds to fund its capital expenditure necessities, broaden the Dahej manufacturing facility and for basic company functions.
Primarily based in Vadodara, Tatva Chintan exports its merchandise to greater than 25 international locations, together with the USA, China, Germany, Japan, South Africa and the UK.
ICICI Securities and JM Financials are the service provider bankers to the problem of Tatva Chintan Pharma.